Loading clinical trials...
Loading clinical trials...
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Conditions
Interventions
Tissue Engineered Vascular Grafts
Locations
1
United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Start Date
July 15, 2020
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2027
Last Updated
June 27, 2025
Lead Sponsor
Nationwide Children's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions